Stock Events

Stock Events

Oramed Pharmaceuticals (ORMP) Q1 2025 Earnings

27MarConfirmed

Q2 2024

Q3 2024

Q4 2024

Q1 2025

-0.48

-0.25

-0.01

0.22

Details

Expected EPS

-0.02

Actual EPS

-0.25

Surprise EPS

-0.23

Surprise Percent

+1,150%

Description

Oramed Pharmaceuticals (ORMP) has reported earnings of -0.25 per share for Q1 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.